With the arrival of October each year, the color pink dominates the scene, from social media platforms to the facades of health institutions and companies, to remind us of breast cancer and the importance of early detection, and to express solidarity with patients and survivors. But behind this global symbol, a fundamental question arises: Is spreading awareness enough to confront the disease, or do prevention and treatment require health equity that ensures every woman has an equal opportunity to access care?
From an individual initiative to a global symbol
The pink ribbon did not emerge as a global symbol for breast cancer awareness out of thin air; rather, it was the result of years of initiatives and campaigns that sought to break the silence surrounding the disease and encourage women to undergo early screening.
Organized efforts for breast cancer awareness began in the United States in 1985, when the American Cancer Society launched a campaign in collaboration with Imperial Chemical Industries, aimed at encouraging women to undergo mammograms. The following year, the campaign expanded to include the entire month of October, which later became an annual date for awareness of the disease.
As for the story of the ribbon, it dates back to 1991, when American activist Charlotte Haley began distributing peach-colored ribbons, accompanied by cards criticizing the limited spending on cancer prevention research and demanding more attention and resources be directed to this field.
In 1992, Alexandra Penney, editor of Self magazine, and Evelyn Lauder, of the Estée Lauder company, contributed to the spread of the pink ribbon through a large-scale campaign, and over time it became an international symbol for breast cancer awareness and solidarity with those affected by it.
However, the widespread use of the symbol opened the door to questions about its commercial exploitation, especially with the emergence of what is known as "pinkwashing," where companies use the color to promote their products without clarifying the extent of their actual contributions to scientific research or patient support.
The criticism here is not directed at the private sector's participation in awareness campaigns, but rather at the necessity that marketing messages be accompanied by clear and transparent contributions whose impact can be measured in improving healthcare and supporting patients.
Breaking the silence and confronting the stigma
In many Arab societies, the name "breast cancer" is still surrounded by caution, and is replaced by expressions such as "the malignant disease," as if mentioning it explicitly might invite it or open a door to fear.
But this silence goes beyond the boundaries of language, as it may push some women to delay screening or avoid medical consultation for fear of diagnosis or the reactions of family and society.
Stigma is sometimes manifested in hiding the family history of the disease, hesitation in talking about symptoms, or the fear that a woman will be reduced to her identity as a patient. Breast cancer is also associated for some women with fears that affect their self-image, particularly regarding the impact of surgery and treatment on the shape of the body and femininity.
In this context, the importance of awareness campaigns goes beyond merely providing medical information; they provide women with a space to talk about their experiences, seek help, and deal with the disease as a health issue rather than a cause for shame.
When a woman talks about her diagnosis publicly, or a doctor shares her personal experience with the disease, it helps dismantle stereotypes and alleviate the feeling of isolation and fear in others.
The importance of these efforts increases given that breast cancer is one of the most common types of cancer among women in the world, according to the World Health Organization, which makes the continued silence around it an obstacle to prevention, diagnosis, and care.
Early detection.. an important step that is not enough on its own
Early detection is based on discovering breast cancer at an early stage, whether through screening programs recommended for women in appropriate age groups, or by paying attention to changes in the breast and seeking medical evaluation without delay.
Pink October campaigns seek to establish a fundamental concept: that healthcare should not only begin when pain is felt or clear symptoms appear, but must be based on prevention and appropriate medical follow-up.
Detecting the disease in its early stages may allow for broader treatment options and contribute to improving the chances of controlling it and surviving. It may also allow, in some cases, for breast-conserving surgery instead of a full mastectomy, depending on the type, stage, and characteristics of the tumor.
However, early detection does not mean a guaranteed cure in all cases, and appropriate tests and their timing vary according to age, risk factors, and established medical recommendations.
Despite the importance of this step, the decision to get screened does not always depend on knowledge alone. A woman may be convinced of its necessity, but she cannot afford the cost, cannot find a nearby medical center, or finds it difficult to reconcile work schedules with family responsibilities.
She may also face psychological fears related to the result, or need the support and backing of her family before proceeding with the screening.
Therefore, early detection cannot be reduced to advice given to a woman to take care of her health; it must be accompanied by the provision of affordable services, nearby facilities, trained staff, and an environment that respects privacy and treats patients with humanity.
Initiatives that turn experience into social impact
In some experiences, the response to the disease did not stop at the limits of awareness, but turned into institutions and initiatives that provide direct services to women.
In Egypt, the establishment of "Baheya" hospital is linked to the story of Mrs. Baheya Wahbi, who faced difficulties in obtaining radiation therapy and had to travel abroad to receive it. After her death, her children decided to turn her wish to provide treatment within her country into reality, so they founded a hospital specialized in the early detection and treatment of breast cancer for free.
In Saudi Arabia, Dr. Samia Al-Amoudi, a consultant obstetrician and gynecologist, went through the experience of breast cancer in 2006. She chose to share her experience publicly, using her medical expertise to confront the stigma and promote awareness of the disease.
Her name became associated with health education efforts and support for scientific research, and with the establishment of the Sheikh Mohammed Hussein Al-Amoudi Center of Excellence in Breast Cancer Care at King Abdulaziz University, which combines care, research, and awareness.
The two experiences, despite their different natures, reveal the importance of turning personal experience and suffering into institutional work that helps women access knowledge and medical services, and eases the burdens of the treatment journey for them.
Field solutions that go beyond major cities
Breast cancer challenges vary from one society to another. In some regions, the main problem is not a lack of information, but the distance of medical centers, the shortage of specialists, and the high costs of transportation, tests, and treatment.
In Senegal, the Senegalese League Against Cancer organizes field initiatives during Pink October, taking screening services to areas outside the capital, Dakar, and allowing women to undergo initial tests with referrals of suspected cases for more specialized evaluations.
In Rwanda, initiatives have focused on training health workers in rural areas to recognize the signs of breast cancer and identify cases that need referral to hospitals, thereby enhancing the role of primary healthcare in detecting the disease.
In Pakistan, awareness initiatives point to utilizing the network of female health workers to reach families, disseminate information related to breast cancer, and identify the signs that require visiting medical facilities.
These models demonstrate that expanding the scope of awareness becomes more effective when it is linked to services capable of receiving women, completing necessary tests, and providing treatment for cases that need it. Recognizing the possibility of infection does not achieve the desired goal if the patient ends up facing a long wait or the inability to afford the cost of the next step.
Health equity.. beyond the pink ribbon
Pink October campaigns have succeeded in moving breast cancer from the circle of silence and embarrassment to public discussion, and its message has become familiar in many societies. But true success is not measured by the spread of the color pink or the number of posts, but by the ability of women to access screening, diagnosis, and treatment in a timely manner.
Awareness alone does not remove the economic, geographical, and social barriers that prevent access to care. It is not enough to ask women to get screened if services are far away or expensive, if waiting lists are long, or if specialized facilities to complete treatment are not available.
Hence, breast cancer awareness turns into a social justice issue when the right to healthcare becomes available to all women, regardless of income level, place of residence, or family circumstances.
This requires integrating screening, diagnosis, and treatment services into basic healthcare and health insurance systems, continuous investment in training medical staff, expanding services in less fortunate areas, and providing psychological and social support to patients and their families.
It also requires distributing responsibility among the woman, her family, health institutions, government agencies, and the private sector, rather than placing the burden of prevention and confronting the disease on women alone.
The pink ribbon gains its true meaning when it turns from a seasonal symbol into a sustainable commitment, from a message calling for awareness into policies that ensure access to care, and from solidarity in words into tangible support that alleviates the suffering of patients.
And when October ends and the pink decorations disappear, the most important question remains: Can every woman who needs a screening get it, and does every patient find a clear and accessible path to treatment?
The answer to these two questions is the true measure of the success of awareness, and the essential step towards health equity that leaves no woman to face the disease alone.
